Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3929427 | 0.71 | FGFR1 (0.30) | — | |
| SCHEMBL3938300 | 0.68 | ALDH1A1 (0.38) | MAPTALDH1A1 | |
| SCHEMBL6345969 | 0.68 | NUDT1 (0.31) | MAPT | |
| SCHEMBL451695 | 0.68 | MAPT (0.39) | MAPTALDH1A1 | |
| SCHEMBL1569404 | 0.65 | — | — | |
| SCHEMBL82882 | 0.62 | EGFR (0.37) | MAPTALDH1A1 | |
| SCHEMBL450208 | 0.62 | GPR3 (0.35) | MAPT | |
| SCHEMBL8727 | 0.62 | ALDH1A1 (0.41) | MAPTALDH1A1 | |
| SCHEMBL1395756 | 0.62 | MAPT (0.33) | MAPT | |
| SCHEMBL9870917 | 0.61 | NPC1 (0.39) | MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0869700-B1 | Electroluminescent devices | XEROX CORP (US) | 2004-03-17 | — | — | EP | claimed |
| US-5932363-A | LUMINESCENT COMPOSITION COMPRISED OF MIXTURE OF FLUORESCENT DYE AND SPECIFIED METAL CHELATE COMPOUND | XEROX CORPORATION (US) | 1999-08-03 | — | — | US | claimed |
| US-5925472-A | Electroluminescent devices | XEROX CORPORATION (US) | 1999-07-20 | — | — | US | claimed |
| EP-0869700-A2 | Electroluminescent devices | Xerox Corporation (US) | 1998-10-07 | — | — | EP | claimed |
| WO-1998033382-A1 | FUNGICIDAL COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998023155-A1 | ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-06-04 | — | — | WO | claimed |
| EP-0825992-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-03-04 | — | — | EP | claimed |
| WO-1996036633-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-11-21 | — | — | WO | claimed |
| WO-1996036229-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-11-21 | — | — | WO | claimed |
| US-20150216861-A1 | CYCLOPROPYL AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2015-08-06 | — | — | US | disclosed |
| US-9029381-B2 | Cyclopropyl amide derivatives | ASTRAZENECA AB (SE) | 2015-05-12 | — | — | US | disclosed |
| EP-2805937-A1 | Cyclopropyl amide derivatives | AstraZeneca AB (SE) | 2014-11-26 | — | — | EP | disclosed |
| EP-2253615-B1 | Cyclopropyl amide derivatives | ASTRAZENECA AB (SE) | 2014-07-09 | — | — | EP | disclosed |
| EP-2195293-B1 | CYCLOPTOPYL AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2013-10-16 | — | — | EP | disclosed |
| US-5942340-A | CHARGE TRANSPORTING COMPONENT CONTAINING INDOLOCARBAZOLE COMPOUND; ENHANCED THERMAL AND OPERATIONAL STABILITY, DURABILITY | XEROX CORPORATION (US) | 1999-08-24 | — | — | US | disclosed |
| US-5932363-A | LUMINESCENT COMPOSITION COMPRISED OF MIXTURE OF FLUORESCENT DYE AND SPECIFIED METAL CHELATE COMPOUND | XEROX CORPORATION (US) | 1999-08-03 | — | — | US | disclosed |
| US-5925472-A | Electroluminescent devices | XEROX CORPORATION (US) | 1999-07-20 | — | — | US | disclosed |
| EP-0906947-A1 | Indolocarbazole electroluminescent devices | XEROX CORPORATION (US) | 1999-04-07 | — | — | EP | disclosed |
| EP-0906948-A1 | Electroluminescent devices | Xerox Corporation (US) | 1999-04-07 | — | — | EP | disclosed |
| EP-0869700-A2 | Electroluminescent devices | Xerox Corporation (US) | 1998-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150216861-A1 | CYCLOPROPYL AMIDE DERIVATIVES | HRH4, HRH2, HRH3 | MAPT 1670/4885ALDH1A1 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.